Search

everythinglearnresearchcommunity

for

Search:↓

Tofacitinib works better and is more tolerable for severe alopecia than conventional treatments and DPCP immunotherapy.

New targeted cancer drugs can cause skin side effects, and managing them requires patient education and timely care.

Ethinylestradiol/chlormadinone acetate may be an effective and well-tolerated treatment for skin conditions caused by excess androgens.

Gray hair can potentially be reversed, leading to new treatments.

New cancer treatments are less harmful to hair but can still cause hair loss, color, shape, and growth changes.

LED therapy is safe and shows potential for treating skin conditions and promoting hair growth, but more research is needed.

Topical L-thyroxine may help with wound healing and hair growth but should be used short-term due to potential risks.

Tracnil™, a mix of myo-inositol, folic acid, and vitamin D3, safely reduced acne, improved excessive hair growth, and fixed irregular periods in overweight women with PCOS.

Some alternative vitiligo treatments show promise, but none are as effective as psoralens and UVA.

New treatments for severe hair loss often fail, but some patients see hair regrowth with specific therapies, and treatment should be tailored to the individual's situation.

Hormonal therapies might help treat hidradenitis suppurativa, but treatment is complex and personalized.

Understanding drug interactions, side effects, and patient-specific factors is crucial for effective dermatological care.

Leptin, a hormone from fat cells, affects immune responses and can influence skin diseases and hair growth.

New therapies for alopecia areata show potential but need more research.

New cytokine-targeted therapies show promise for treating alopecia areata.

Light-based therapies show promise as safe treatments for hair loss.

Alopecia areata treatment should be personalized, using topical or systemic therapies based on severity, with promising options like JAK inhibitors needing more research.

New regenerative therapies show promise for treating hair loss.

Current treatments for folliculitis decalvans include antibiotics, isotretinoin, and potential new therapies like botulinum toxin A and PRP.

Alopecia Areata significantly lowers quality of life and current treatments are inadequate, highlighting a need for better therapies and standardized treatment protocols.

Menopause worsens skin, hair, and nails, affecting self-esteem and quality of life.

Dermatologists are essential in helping transgender and gender diverse patients with skin and hair issues related to gender affirmation and hormone therapy.

The COVID-19 quarantine in Turkey disrupted dermatological care, increased stress-related skin issues, and showed the need for psychological support and teledermatology.

Plasma therapy is becoming more popular for treating viral infections, skin conditions, and orthopedic issues, and is expected to grow in the healthcare market.

Effective treatments for scalp psoriasis include glucocorticosteroids, Vitamin D3 analogs, and combination therapies like calcipotriol and betamethasone dipropionate.

PRP and cell therapies may help with hair loss, but more research is needed.

Some skin medications can have harmful interactions with the COVID-19 drug nirmatrelvir-ritonavir, but not with molnupiravir.

2011 dermatological research found new skin aging markers, hair loss causes, skin defense mechanisms, and potential for new treatments.

Secretome-based therapies could improve hair growth better than current treatments.

Some diets and supplements might help with skin disorders, but their effectiveness varies and more research is needed.